Skip to main content

Scilex Holding Co

SCLXW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001820190

No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $16.4K in total; no superinvestor holds it.

Other share classesSCLX

Q1 2023 vs. Q4 2022

How the institutions holding Scilex Holding Co changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of SCLXW: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders2610−16
Shares2.17M403.0K−1.76M (−81.4%)
Value$356.1K$1.49M+$1.14M (+319.7%)

New holders (2)

Institutions that held Scilex Holding Co at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to SCLXW in Q1 2023
InstitutionSharesValue% of portfolio
Perigon Wealth Management, LLC27,301$28.7K0.00%
Pura Vida Investments, LLC12,699$13.3K0.00%

Sold out (18)

Institutions that held Scilex Holding Co at the end of Q4 2022 and filed for Q1 2023 without it.